| Net Cash Provided by (Used in) Operating Activities |
-202M |
USD |
-602% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
278M |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
-75.9M |
USD |
-1474% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
350M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
24.9M |
shares |
+5.97% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
577K |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
53.4M |
USD |
+19.5% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
17.5M |
USD |
+13.5% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
30M |
USD |
-7.54% |
Q4 2024 |
FY 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
17.1M |
USD |
-78.7% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
37.5M |
USD |
-8.01% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
474M |
USD |
+2.8% |
Q3 2025 |
Q3 2025 |
| Share-based Payment Arrangement, Expense |
1.11M |
USD |
-53% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
66.7M |
USD |
-4.37% |
Q1 2024 |
Q1 2024 |